Home

Platinum-Montaur Life Sciences, LLC

CIK 1404598 · last filed 2014-12-22

Platinum-Montaur Life Sciences, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2013. The most recent filing, for ECTE, was dated Dec 22, 2014. Across all open-market trades the lifetime net is +$1.5M, making them a net buyer over the disclosed history. The firm reports its address in New York, NY. 12 SEC filings were submitted jointly with Platinum Partners Value Arbitrage Fund, LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

3

Lifetime Open-Market Net

$1.53M

Filer Profile

Reported Address
152 WEST 57TH STREET
4TH FLOOR
NEW YORK, NY 10019
Phone
(212) 582-2222
State of Incorporation
DE
Related Filers
Platinum Partners Value Arbitrage Fund, LP — 12 joint filings, latest 2015-05-18
Platinum Management (NY) LLC — 8 joint filings, latest 2015-05-18
Platinum Partners Liquid Opportunity Master Fund L.P. — 8 joint filings, latest 2015-05-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Echo Therapeutics, Inc. (ECTE) Delisted 10%+ Owner 679,922 — — $1.53M 2 2014-12-22

Recent Filings

3 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-12-22 Echo Therapeutics, Inc. (ECTE) Delisted Buy (P) — $0 EDGAR
2013-12-12 Echo Therapeutics, Inc. (ECTE) Delisted Buy (P) +556,552 $1.53M EDGAR
2009-11-04 — Mixed +6,476,408 $1.06M
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.